|
(Health-NewsWire.Net, June 04, 2020 ) [196 Pages Report] The Global In Vivo Toxicology Market is expected to grow at a CAGR of 6.9% during the forecast period to reach to USD 6.14 Billion.
Some key factors driving market growth are the increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests. Factors such as increasing research in oncology and personalized medicine and the rising demand for humanized animal models are expected to offer lucrative opportunities for players in the global market.
Research Methodology
Top-down and bottom-up approaches were used to validate the size of the in vivo toxicology market and estimate the size of other dependent submarkets.
Various secondary sources such as Food and Drug Administration (FDA), United States Environmental Protection Agency (USEPA), National Institute of Environmental Health Sciences (NIEHS), Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC), Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), Federation of European Toxicologists and European Societies of Toxicology (EUROTOX), Institute of Laboratory Animal Sciences (ILAS), National Council for the Control of Animal Experimentation (CONCEA), Organisation for Economic Co-operation and Development (OECD), World Bank, Academic Journals, Company Websites, expert interviews, annual reports, SEC filings, investor presentations, and MarketsandMarkets Analysishave been used to identify and collect information useful for the study of this in vivo toxicology industry.
Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC - Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=105308811
Market Segmentation in Depth:
The consumables segment is expected to hold the largest share of the market
Based on product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models. In 2017, the consumables segment is expected to account for the largest share of the in vivo toxicology market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.
By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period
The in vivo toxicology market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=105308811
The US is estimated to account for the largest share of the in vivo toxicology market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period. Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the in vivo toxicology market in China.
The major players in the global in vivo toxicology market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).
MarketsandMarkets™
Mr. Aashish Mehra
1-888-600-6441
raviraj.tak@marketsandmarkets.com
Source: EmailWire.Com 
|
